Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $571M (98.1% shares, 1.9% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW HEALTH INC | 3,990,000 | $134M | 23.4% | $6.33 | +598.7% | COM | 415858109 |
| TGTX | TG THERAPEUTICS INC | 2,260,000 | $68.03M | 11.9% | $13.67 | +110.0% | COM | 88322Q108 |
| CDXS | CODEXIS INC | 8,840,000 | $42.17M | 7.4% | $2.89 | +42.3% | COM | 192005106 |
| ETON | ETON PHARMACEUTICALS INC | 2,852,070 | $37.99M | 6.6% | $5.71 | +77.6% | COM | 29772L108 |
| OCUL | OCULAR THERAPEUTIX INC | 4,342,500 | $37.08M | 6.5% | $5.10 | +91.5% | COM | 67576A100 |
| ARVN | ARVINAS INC | 1,625,000 | $33.64M | 5.9% | $26.77 | -9.2% | COM | 04335A105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 500,000 | $27.99M | 4.9% | $12.73 | +333.9% | COM | 76243J105 |
| IMNM | IMMUNOME INC | 2,040,000 | $21.66M | 3.8% | $14.15 | -14.6% | COM | 45257U108 |
| LQDA | LIQUIDIA CORPORATION | 1,698,142 | $19.97M | 3.5% | $9.89 | +10.5% | COM NEW | 53635D202 |
| EWTX | EDGEWISE THERAPEUTICS INC | 480,000 | $12.82M | 2.2% | $10.13 | +214.4% | COM | 28036F105 |
| DNA | GINKGO BIOWORKS HOLDINGS | 1,200,000 | $11.78M | 2.1% | $9.56 | -10.4% | Class A New | 37611X209 |
| — | CARGO THERAPEUTICS INC | 750,000 | $10.81M | 1.9% | $15.86 | — | COM | 14179K101 |
| TARA | PROTARA THERAPEUTICS INC | 1,825,000 | $9.636M | 1.7% | $27.06 | -88.1% | COM STK | 74365U107 |
| TRVI | TREVI THERAPEUTICS INC | 2,317,500 | $9.548M | 1.7% | $2.06 | +55.6% | COM | 89532M101 |
| JSPR | JASPER THERAPEUTICS INC | 400,000 | $8.552M | 1.5% | $18.12 | +14.9% | COM NEW | 471871202 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 325,000 | $8.352M | 1.5% | $11.31 | +87.9% | ORDINARY SHARES | N62509109 |
| — | ACELYRIN INC | 2,235,000 | $7.175M | 1.3% | $15.96 | — | COM | 00445A100 |
| NRIX | NURIX THERAPEUTICS INC | 378,500 | $7.131M | 1.2% | $12.50 | +83.4% | COM | 67080M103 |
| XOMA | XOMA CORP DEL | 250,000 | $6.57M | 1.1% | $11.26 | +159.4% | COM NEW | 98419J206 |
| PCVX | VAXCYTE INC | 75,000 | $6.139M | 1.1% | $38.73 | +156.4% | COM | 92243G108 |
| — | GOSSAMER BIO INC | 11,500,000 | $6.09M | 1.1% | $0.43 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 1,767,500 | $5.356M | 0.9% | $3.47 | -5.6% | COM | 98943L107 |
| — | BIODESIX INC | 3,465,000 | $5.301M | 0.9% | $2.17 | — | COM | 09075X108 |
| — | KARYOPHARM THERAPEUTICS INC | 6,000,000 | $4.67M | 0.8% | $0.62 | — | NOTE 3.000%10/1 | 48576UAA4 |
| NUVL | NUVALENT INC | 58,500 | $4.579M | 0.8% | $72.00 | +29.7% | COM | 670703107 |
| GOSS | GOSSAMER BIO INC | 4,490,000 | $4.062M | 0.7% | $1.01 | -14.9% | COM | 38341P102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 105,000 | $4.053M | 0.7% | $17.50 | +149.2% | COM | 74366E102 |
| — | ESSA PHARMA INC | 2,209,998 | $3.956M | 0.7% | $1.79 | — | COM NEW | 29668H708 |
| ABCL | ABCELLERA BIOLOGICS INC | 965,000 | $2.827M | 0.5% | $2.98 | -6.6% | COM | 00288U106 |
| URGN | UROGEN PHARMA LTD | 220,000 | $2.343M | 0.4% | $10.29 | +16.4% | COM | M96088105 |
| RZLT | REZOLUTE INC | 465,000 | $2.279M | 0.4% | $4.59 | +9.7% | COM NEW | 76200L309 |
| IMTX | IMMATICS NV | 165,000 | $1.173M | 0.2% | $8.59 | 0.0% | ORDINARY SHARES | N44445109 |
| IBIO | IBIO INC | 375,000 | $919K | 0.2% | $1.26 | +104.3% | COM NEW | 451033708 |
| LXEO | LEXEO THERAPEUTICS INC | 130,000 | $855K | 0.1% | $7.88 | 0.0% | COM | 52886X107 |
| RGNX | REGENXBIO Inc | 80,000 | $618K | 0.1% | $9.39 | 0.0% | COM | 75901B107 |
| VTYX | VENTYX BIOSCIENCES | 280,000 | $613K | 0.1% | $2.27 | 0.0% | COM | 92332V107 |
| PEPG | PEPGEN INC | 110,000 | $417K | 0.1% | $11.83 | -47.3% | COM | 713317105 |
| STOK | STOKE THERAPEUTICS INC | 25,000 | $276K | 0.0% | $12.29 | 0.0% | COM | 86150R107 |
| ADGM | ADAGIO MED HLDGS INC | 110,571 | $116K | 0.0% | $4.76 | -49.3% | COM | 00534B100 |